Louise Chen Score: 44
Analyst at
Scotiabank
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+145.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
71%
12 W / 5 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
64%
9 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
21%
3 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
21%
3 W / 11 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
67%
6 W / 3 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
71%
12 W / 5 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 05, 2026 |
AMGEN Inc.
AMGN
|
BUY |
$450.00
Est. +11%
|
$406.25 | $447.01 |
Bullseye Hit (±1%)
|
$437.23
+7.6%
|
| Feb 13, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$558.00
Est. +13%
|
$493.98 | $560.25 |
Bullseye Hit (±1%)
|
$546.12
+10.6%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$177.00
Est. +14%
|
$155.29 | $157.27 |
Pending
|
$151.00
-2.8%
|
| Jan 09, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +7%
|
$55.87 | $68.24 |
Target Met
|
$66.82
+19.6%
|
| Dec 04, 2025 |
Merck & Co Inc
MRK
|
BUY |
$120.00
Est. +18%
|
$101.88 | $156.91 |
Target Met
|
$150.34
+47.6%
|
AMGEN Inc.
AMGN
Aug 05, 2026
Signal & Target
BUY
$450.00
Start Price
$406.25
Best Price (1Y)
$447.01
Current Price
$437.23
Return
+7.6%
Vertex Pharmaceuticals, Inc.
VRTX
Feb 13, 2026
Signal & Target
BUY
$558.00
Start Price
$493.98
Best Price (1Y)
$560.25
Current Price
$546.12
Return
+10.6%
Gilead Sciences, Inc.
GILD
Feb 11, 2026
Signal & Target
BUY
$177.00
Start Price
$155.29
Best Price (1Y)
$157.27
Current Price
$151.00
Return
-2.8%
Bristol-Myers Squibb Co.
BMY
Jan 09, 2026
Signal & Target
BUY
$60.00
Start Price
$55.87
Best Price (1Y)
$68.24
Current Price
$66.82
Return
+19.6%
Merck & Co Inc
MRK
Dec 04, 2025
Signal & Target
BUY
$120.00
Start Price
$101.88
Best Price (1Y)
$156.91
Current Price
$150.34
Return
+47.6%